Emphysema subtypes, identified via CT, may be linked to cardiopulmonary subphenotypes that can help to target cardiac care in early COPD.

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

The FDA is implementing stricter guidance for the approval of COVID-19 vaccines, according to a paper published in The New England Journal of Medicine.

Pediatric and OB-GYN health care providers react to HHS Secretary Robert F. Kennedy Jr’s announcement on COVID-19 vaccine ...

RFK Jr talked about stopping NIH-funded researchers from publishing in The Lancet, New England Journal of Medicine, and JAMA.

Sustained tuberculosis infection rates among adolescents were not lower following BCG revaccination vs placebo.

The WHO has designated new COVID-19 variant NB.1.8.1 a "variant under monitoring" in response to its growing prevalence.

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

In vivo platelet activation and related pathways may be linked to small airways disease and pulmonary vascular changes in smokers.

Topline data were announced from a phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in participants with obstructive sleep apnea.

NIH staff walked out of a town hall after Director Dr Jay Bhattacharya suggested NIH-funded research created COVID-19.